Skip to content

Effectiveness of Probiotic Supplementation in Reducing Halitosis Among Older Adults

Effectiveness of Lacticaseibacillus paracasei TISTR 2688 in Reducing Halitosis and Improving Oral Health Parameters in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260421002
Enrollment
30
Registered
2026-04-21
Start date
2024-12-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Halitosis Halitosis, Probiotics, Lacticaseibacillus paracasei, Oral health, Older adults, Randomized controlled trial, Crossover study

Interventions

Probiotic supplementation containing Lacticaseibacillus paracasei TISTR 2688 will be administered orally once daily, with a matched placebo used in a randomized double blind crossover design including
Experimental Dietary Supplement,Placebo Comparator Dietary Supplement
Probiotic containing Lacticaseibacillus paracasei TISTR 2688,Placebo

Sponsors

Naresuan University, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Aged 60 years and older 2.Clinically diagnosed with halitosis 3.Willing to participate and provide written informed consent 4.Able to comply with study procedures and follow up visits 5.Generally healthy or with stable systemic conditions

Exclusion criteria

Exclusion criteria: 1.Use of antibiotics, probiotics, or antimicrobial mouthwash within the past 4 weeks 2.Presence of severe periodontal disease requiring immediate treatment 3.History of systemic diseases that may affect oral malodor such as uncontrolled diabetes or gastrointestinal disorders 4.Smoking or alcohol consumption that may affect oral odor assessment 5.Use of medications known to cause halitosis 6.Cognitive impairment or inability to comply with study procedures 7.Allergies or contraindications to probiotic products

Design outcomes

Primary

MeasureTime frame
Volatile sulfur compound levels Baseline, after first intervention period, after washout period, and after second intervention period Halitosis measured by volatile sulfur compound levels and organoleptic score; tongue coating and plaque assessed by clinical indices

Secondary

MeasureTime frame
Gingival bleeding index Bleeding on probing Gingival inflammation Baseline, after first intervention period, after washout period, and after second intervention period Gingival bleeding assessed using gingival bleeding index by recording bleeding after gentle probing with a periodontal probe.

Countries

Thailand

Contacts

Public ContactPatcharaphol Samnieng

Naresuan University

patcharapols@nu.ac.th0876994897

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026